| Dr Scott Preston Eichelberger, MD | |
|
500 Discovery Dr, Suite 302, Chesapeake, VA 23320-3871 | |
| (757) 668-2500 | |
| (757) 668-2510 |
| Full Name | Dr Scott Preston Eichelberger |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 500 Discovery Dr, Chesapeake, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467486027 | NPI | - | NPPES |
| 6729983 | Medicaid | VA | |
| 890569I | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 0101044983 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Preston Eichelberger, MD 500 Discovery Dr, Suite 302, Chesapeake, VA 23320-3871 Ph: (757) 668-2500 | Dr Scott Preston Eichelberger, MD 500 Discovery Dr, Suite 302, Chesapeake, VA 23320-3871 Ph: (757) 668-2500 |
News Archive
The National Hispanic Science Network on Drug Abuse awarded the National Award of Excellence in Research by a New Investigator to Alice Cepeda, sociology professor and associate director of the Center for Drug and Social Policy Research, Graduate College of Social Work, University of Houston. Cepeda will be honored Sept. 30 at the organization's annual conference in New Orleans.
COVID SHIELD is a major collaborative effort led by the Walter and Eliza Hall Institute of Medical Research in partnership with human data science company IQVIA.
Bristol-Myers Squibb Company today announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientific understanding of immuno-oncology. Immuno-oncology focuses on the potential of harnessing the intelligence of the body's own immune system to fight cancer.
ARMGO Pharma and the Muscular Dystrophy Association today announced that $1 Million has been awarded for preclinical work in support of an Investigational New Drug application with the U.S. Food and Drug Administration for ARM210, a novel, orally available, small-molecule Rycal drug that has potential as a treatment for Duchenne muscular dystrophy.
› Verified 2 days ago
Thedia J Smith, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 733 Volvo Pkwy, Suite 200, Chesapeake, VA 23320 Phone: 757-547-5851 Fax: 888-371-4920 | |
Dr. Michelle Davis Eichelberger, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 500 Discovery Dr, Suite 302, Chesapeake, VA 23320 Phone: 757-668-2500 Fax: 757-668-2510 | |
Mrs. Rachel Ann Mcclanahan, CPNP-PC Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 656 Independence Pkwy, Chesapeake, VA 23320 Phone: 757-410-3630 | |
Zaharoula Viennas, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 817 Volvo Pkwy, Chesapeake, VA 23320 Phone: 757-668-4630 | |
Dr. Luis F. Olmedo, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 817 Volvo Pkwy, Chesapeake, VA 23320 Phone: 757-668-4630 | |
Takara S Jobe, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 500 Discovery Dr, Suite 302, Chesapeake, VA 23320 Phone: 757-668-2500 Fax: 757-668-2510 | |
Dionne N Harewood, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4012 Raintree Rd, Suite 200a, Chesapeake, VA 23321 Phone: 757-488-2223 Fax: 757-488-8398 |